Topic Archives: Xeljanz

Latest Updates on Paraquat Parkinson’s Disease Lawsuits To Be Reviewed During MDL Conference on December 19 (Posted 3 days ago)

A federal judge has scheduled a status conference for December 19 for parties involved in Paraquat Parkinson's disease litigation to discuss the next steps toward holding bellwether trials.

MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025 (Posted 7 days ago)

With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.

Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for September 8, 2025 (Posted 8 days ago)

The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.